Vidya Therapeutics Overview
- Year Founded
-
2024
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Vidya Therapeutics General Information
Description
Developer of biotechnology products designed to treat immune-mediated and neuroinflammatory diseases. The company's technology utilizes central nervous system-penetrant, covalent inhibitors to achieve selective target engagement at low doses, providing the healthcare market with oral therapeutic agents for autoimmune and allergic conditions.
Contact Information
Website
www.vidyatx.com(Operating Subsidiary)
Corporate Office
- 162 South Rancho Santa Fe Road
- Suite E70
- Encinitas, CA 92024
- United States
Corporate Office
- 162 South Rancho Santa Fe Road
- Suite E70
- Encinitas, CA 92024
- United States
Vidya Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vidya Therapeutics FAQs
-
When was Vidya Therapeutics founded?
Vidya Therapeutics was founded in 2024.
-
Where is Vidya Therapeutics headquartered?
Vidya Therapeutics is headquartered in Encinitas, CA.
-
What industry is Vidya Therapeutics in?
Vidya Therapeutics’s primary industry is Drug Discovery.
-
Is Vidya Therapeutics a private or public company?
Vidya Therapeutics is a Private company.
-
What is the current valuation of Vidya Therapeutics?
The current valuation of Vidya Therapeutics is .
-
What is Vidya Therapeutics’s current revenue?
The current revenue for Vidya Therapeutics is .
-
When was Vidya Therapeutics acquired?
Vidya Therapeutics was acquired on 29-Jul-2026.
-
Who acquired Vidya Therapeutics?
Vidya Therapeutics was acquired by Processa Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process